Expert interview with Justin Gainor and Stevan Bradford
In this video podcast, Prof. Justin Gainor and patient advocate Stevan Bradford discuss the lived experience of NTRK fusion–positive NSCLC, covering the path to diagnosis, the importance of biomarker testing, and the challenges of starting treatment. They share practical insights on targeted therapy, side effect management, and improving communication and personalized care, highlighting the vital role of the patient voice in precision oncology.